118 related articles for article (PubMed ID: 11753211)
1. Differential clearance and induction of host responses by various administered or released lipopolysaccharides.
Hasunuma R; Morita H; Tanaka S; Ryll R; Freudenberg MA; Galanos C; Kumazawa Y
J Endotoxin Res; 2001; 7(6):421-9. PubMed ID: 11753211
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide responsiveness is an important factor in the generation of optimal antigen-specific T cell responses during infection with gram-negative bacteria.
Marshall NE; Ziegler HK
J Immunol; 1991 Oct; 147(7):2333-9. PubMed ID: 1918965
[TBL] [Abstract][Full Text] [Related]
3. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
4. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
Lee JW; Paape MJ; Zhao X
Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
[TBL] [Abstract][Full Text] [Related]
5. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay.
Dehus O; Hartung T; Hermann C
J Endotoxin Res; 2006; 12(3):171-80. PubMed ID: 16719988
[TBL] [Abstract][Full Text] [Related]
7. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.
Heumann D; Lauener R; Ryffel B
J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725
[TBL] [Abstract][Full Text] [Related]
8. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma.
Murphey ED; Fang G; Varma TK; Sherwood ER
Shock; 2007 Mar; 27(3):289-95. PubMed ID: 17304110
[TBL] [Abstract][Full Text] [Related]
9. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways.
Gangloff SC; Hijiya N; Haziot A; Goyert SM
Clin Infect Dis; 1999 Mar; 28(3):491-6. PubMed ID: 10194066
[TBL] [Abstract][Full Text] [Related]
11. Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli.
Wu G; Fan X; Li L; Wang H; Ding J; Hongbin W; Zhao R; Gou L; Shen Z; Xi T
Int J Antimicrob Agents; 2010 Mar; 35(3):250-4. PubMed ID: 20045294
[TBL] [Abstract][Full Text] [Related]
12. The significance of high-density lipoproteins (HDL) in the clearance of intravenously administered bacterial lipopolysaccharides (LPS) in mice.
König V; Hopf U; Möller B; Lobeck H; Assmann G; Freudenberg M; Galanos C
Hepatogastroenterology; 1988 Jun; 35(3):111-5. PubMed ID: 3042575
[TBL] [Abstract][Full Text] [Related]
13. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.
Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061
[TBL] [Abstract][Full Text] [Related]
14. Reactive nitrogen intermediate production and tolerance variability in different mouse strains after in vivo treatment with lipopolysaccharide from Salmonella abortus equi.
Nahrevanian H; Salmasi JG; Farahmand M; Aghighi Z; Assmar M; Abolhassani M
J Microbiol Immunol Infect; 2005 Jun; 38(3):164-8. PubMed ID: 15986065
[TBL] [Abstract][Full Text] [Related]
15. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
Kitchens RL; Thompson PA
J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
18. Local skin reaction in mice and guinea pigs induced by a single intradermal inoculation of Fusobacterium necrophorum lipopolysaccharide.
Kanoe M; Kiritani M; Inoue M
Microbios; 1995; 81(327):93-101. PubMed ID: 7476558
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
20. Elution of lipopolysaccharides from polyacrylamide gels.
Hardy E; Pupo E; Santana H; Guerra M; Castellanos-Serra LR
Anal Biochem; 1998 May; 259(1):162-5. PubMed ID: 9606157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
